| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/02/2011 | EP2289938A2 Use of Panton-Valentine Leukocidin for treating and preventing staphylococcus infections |
| 03/02/2011 | EP2289937A1 Production of monoclonal antibodies in vitro |
| 03/02/2011 | EP2289936A1 Immunoglobulin variants and uses thereof |
| 03/02/2011 | EP2289910A2 Differential in tumour gene products and use of same |
| 03/02/2011 | EP2289909A1 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 03/02/2011 | EP2289907A2 Streptococcus agalactiae antigens I + II |
| 03/02/2011 | EP2289618A1 Asymmetric porous adsorptive beads |
| 03/02/2011 | EP2289559A1 Anit-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 03/02/2011 | EP2289552A1 An immunosuppressive agent plus anti-TCR antibodies for the induction of chimerism in transplantation |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289550A2 Ultra high affinity neutralizing antibodies |
| 03/02/2011 | EP2289549A2 Immunoconjugates for treating cancer |
| 03/02/2011 | EP2289543A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody |
| 03/02/2011 | EP2289534A1 Modulation of NKG2D |
| 03/02/2011 | EP2288719A2 Methods for diagnosis of clostridium diffcile and methods and vectors for recombinant toxin expression |
| 03/02/2011 | EP2288717A1 Monoclonal antibodies to basic fibroblast growth factor |
| 03/02/2011 | EP2288702A1 Combination therapies against cancer |
| 03/02/2011 | EP2288693A1 Novel astrovirus |
| 03/02/2011 | EP2288623A2 Method of generating single vl domain antibodies in transgenic animals |
| 03/02/2011 | EP2288382A2 Anti- il-17a/il-17f cross-reactive antibodies and methods of use thereof |
| 03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 03/02/2011 | EP1984736B1 Cd86 and cd80 receptor competition assays |
| 03/02/2011 | EP1934258B1 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 03/02/2011 | EP1833850B1 Framework residue substituted humanized col-1 antibodies and their use |
| 03/02/2011 | EP1771475B1 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 03/02/2011 | EP1673633B9 Method for detecting feline immunodeficiency virus |
| 03/02/2011 | EP1663320B1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |
| 03/02/2011 | EP1513937B1 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein |
| 03/02/2011 | EP1513934B1 Genes and polypeptides relating to human colon cancers |
| 03/02/2011 | EP1495056B1 Methods of analyzing antibody disulfide isomers |
| 03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
| 03/02/2011 | EP1287123B1 Subtilisin variant |
| 03/02/2011 | EP1163337B1 Vascular adhesion molecules and modulation of their function |
| 03/02/2011 | CN1832965B Endothelial cell specific antibodies and uses thereof |
| 03/02/2011 | CN1714150B Genetic products differentially expressed in tumors and the use thereof |
| 03/02/2011 | CN101983208A 胰高血糖素受体拮抗剂 Glucagon receptor antagonists |
| 03/02/2011 | CN101983207A Anti mif antibodies |
| 03/02/2011 | CN101983071A Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin' s lymphomas |
| 03/02/2011 | CN101982777A Duck plague virus antigen capturing ELISA method based on anti-recombination UL51 albumen antibody |
| 03/01/2011 | US7897760 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 03/01/2011 | US7897743 Humanized GM-CSF antibodies |
| 03/01/2011 | US7897733 Rapamycin conjugates and antibodies |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897731 Corticotropin releasing factor 2 receptor agonists |
| 03/01/2011 | US7897730 TRAIL receptor-binding agents and uses of the same |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897726 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
| 03/01/2011 | US7897352 Stabilizing agents and capture ligands for use in assays measuring analyte concentrations |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897350 Immunological assay and antibodies for anti-mullerian hormone |
| 03/01/2011 | US7897349 Using presence of lymphokine in urine, bladder and/or prostatic tissues as diagnostic/prognostic tool in detection of pelvic diseases |
| 03/01/2011 | US7897347 Selection of intracellular immunoglobulins |
| 03/01/2011 | US7897343 Propagating attenuated lelystad agent in host cells for use in generating vaccine for prevention and treatment of procine respiratory infection |
| 03/01/2011 | US7897332 Immunoglobulin for detecting lymphadenopathy associated viral infections; immunodiagnostics |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | US7897149 Fully human anti-VAP-1 monoclonal antibodies |
| 03/01/2011 | US7897148 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
| 03/01/2011 | US7897139 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 03/01/2011 | CA2342203C Method for removal of hiv and other viruses from blood |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/01/2011 | CA2301709C Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 03/01/2011 | CA2217820C Milk and milk products for preventing or treating heart disease |
| 02/24/2011 | WO2011022725A2 Mimotopes of hiv and uses thereof |
| 02/24/2011 | WO2011022503A1 New astrovirus species |
| 02/24/2011 | WO2011022438A2 Cleavage sensitive antibodies and methods of use thereof |
| 02/24/2011 | WO2011022077A2 A nucleic acid cassette for producing recombinant antibodies |
| 02/24/2011 | WO2011021386A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
| 02/24/2011 | WO2011021381A1 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient |
| 02/24/2011 | WO2011021146A1 Osteopontin antibodies |
| 02/24/2011 | WO2011021009A1 Variant immunoglobulins with improved manufacturability |
| 02/24/2011 | WO2011020925A1 Anti-cmet antibody and its use for the detection and the diagnosis of cancer |
| 02/24/2011 | WO2011020529A2 Antibodies for the detection of integrin complexes in ffpe material |
| 02/24/2011 | WO2011020155A1 Anti p2x7 receptor antibodies and fragments thereof |
| 02/24/2011 | WO2010149641A3 Pharmaceutical agent |
| 02/24/2011 | WO2010147686A3 Methods of purifying small modular immunopharmaceutical proteins |
| 02/24/2011 | WO2010139808A3 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| 02/24/2011 | WO2010136508A3 Stem cell targeting |
| 02/24/2011 | WO2010136492A3 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye. |
| 02/24/2011 | WO2010109165A3 Soluble "heavy-chain only " antibodies |
| 02/24/2011 | WO2010108126A3 Reprogramming compositions and methods of using the same |
| 02/24/2011 | WO2010104749A3 Antigen presenting cell targeted cancer vaccines |
| 02/24/2011 | WO2010088522A3 Novel lowered affinity antibodies and uses therefor |
| 02/24/2011 | WO2010080769A4 Chemotherapeutic methods and compositions |
| 02/24/2011 | WO2010053772A3 Disease-associated antigens and methods of use thereof |
| 02/24/2011 | WO2010040508A8 Bispecific anti-vegf/anti-ang-2 antibodies |
| 02/24/2011 | US20110046355 Cytotoxic immunoglobulin |
| 02/24/2011 | US20110046354 Humanized High Affinity Recombinant Antibody Against Hepatitis B Surface Antigen |
| 02/24/2011 | US20110046353 Purification Process for Anitbody Fragments Using Derivatized Triazines as Affinity Ligands |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046075 Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046061 Coagulation factor VII compositions and methods of making and using same |
| 02/24/2011 | US20110046038 Polypeptide-Polymer Conjugates and Methods of Use Thereof |
| 02/24/2011 | US20110046000 Methods to increase the photostability of dyes |
| 02/24/2011 | US20110045603 Serine, Threonine, and Tyrosine Phosphorylation Sites |